根据最终合并协议,Viewpoint的每一股已发行和流通股份将转换为获得Isoray 3.3212股的权利。Viewpoint股东将拥有Isoray完全稀释的流通股49%的股份。
$华海药业(SH600521)$ $华东医药(SZ000963...查看全文
$Isoray(ISR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-21-002347 Act: 34 Size: 3 MB 网页链接
$Isoray(ISR)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001437749-21-002324 Act: 34 Size: 179 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-21-002002 Act: 33 Size: 413 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 1.01 and 9.01 Accession Number: 0001437749-21-002004 Act: 34 Size: 244 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-21-001871 Act: 33 Size: 413 KB 网页链接
$Isoray(ISR)$ 8-K Current report, items 2.02 and 8.01 Accession Number: 0001437749-21-001863 Act: 34 Size: 27 KB 网页链接
$Isoray(ISR)$ 8-K Current report, item 5.07 Accession Number: 0001437749-20-025197 Act: 34 Size: 41 KB 网页链接
$Isoray(ISR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001437749-20-024716 Size: 4 KB 网页链接
$Isoray(ISR)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001437749-20-024110 Act: 33 Size: 569 KB 网页链接
$Isoray(ISR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-20-023837 Act: 34 Size: 2 MB 网页链接